Adriano C Coelho Selected Research

Visceral Leishmaniasis (Kala Azar)

7/2023	In Vitro Drug Susceptibility of a Leishmania (Leishmania) infantum Isolate from a Visceral Leishmaniasis Pediatric Patient after Multiple Relapses.
9/2022	Isolation, typing, and drug susceptibility of Leishmania (Leishmania) infantum isolates from dogs of the municipality of Embu das Artes, an endemic region for canine leishmaniasis in Brazil.
3/2021	Susceptibility to paromomycin in clinical isolates and reference strains of Leishmania species responsible for tegumentary leishmaniasis in Brazil.
12/2020	Activity of paromomycin against Leishmania amazonensis: Direct correlation between susceptibility in vitro and the treatment outcome in vivo.
1/2020	The preclinical discovery and development of oral miltefosine for the treatment of visceral leishmaniasis: a case history.
2/2015	Generation of luciferase-expressing Leishmania infantum chagasi and assessment of miltefosine efficacy in infected hamsters through bioimaging.
7/2014	In vitro and in vivo miltefosine susceptibility of a Leishmania amazonensis isolate from a patient with diffuse cutaneous leishmaniasis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Adriano C Coelho Research Topics

Disease

17	Leishmaniasis 07/2023 - 08/2003
7	Visceral Leishmaniasis (Kala Azar) 07/2023 - 07/2014
5	Cutaneous Leishmaniasis 11/2021 - 02/2015
2	Infections 05/2016 - 01/2016
2	Diffuse Cutaneous Leishmaniasis 01/2016 - 07/2014
1	Neglected Diseases 01/2020
1	Polyploidy 04/2013

Drug/Important Bio-Agent (IBA)

10	miltefosine (Impavido)IBA 03/2023 - 01/2012
5	Pentamidine (NebuPent)FDA LinkGeneric 03/2021 - 08/2003
3	Paromomycin (Paromomycin Sulfate)FDA LinkGeneric 09/2022 - 12/2020
2	Ribosomal DNA (rDNA)IBA 07/2023 - 11/2021
2	Amphotericin B (Amphotericin)FDA LinkGeneric 03/2023 - 03/2021
2	Anti-Bacterial Agents (Antibiotics)IBA 03/2021 - 12/2020
2	AminoglycosidesIBA 03/2021 - 12/2020
2	Drug CombinationsIBA 01/2018 - 12/2015
2	Tamoxifen FDA LinkGeneric 05/2016 - 12/2015
2	LuciferasesIBA 01/2016 - 02/2015
2	AntimonyIBA 04/2013 - 03/2004
1	amsonic acid (DAS)IBA 09/2022
1	NucleotidesIBA 11/2021

Therapy/Procedure

9	Drug Therapy (Chemotherapy) 07/2023 - 05/2011
1	Splenectomy 07/2023
1	Therapeutics 05/2016